AFT Pharmaceuticals raises $9.1M via redeemable share issue, announces SPP

Rebecca Howard
Thu, 16 Mar 2017

By Rebecca Howard March 17 (BusinessDesk) -  AFT Pharmaceuticals, which manufactures the Maxigesic painkiller, raised new funds through a redeemable share issue to fuel international growth and announced plans to raise more capital in a share purchase plan. The Auckland-based drug maker said the redeemable share issue raised approximately $9.1 million from CRG, a US health-care investor, and the Atkinson Family Trust at $2.74 per share, equal to the volume weighted average price of AFT's ordinary shares on the NZX over the last five busin...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Property
A 'reasonably difficult' thorn in Thiel’s Wānaka site
Brent Melville | Wed, 25 May 2022

Whether Peter Thiel's rich lister lodge falls within the 'visual requirements' for an outstanding natural landscape has become the central theme in his battle with the local authority.

Economy
RBNZ raises rates by 50 basis points to 2.0%
Rebecca Howard | Wed, 25 May 2022

The central bank sees the OCR peaking at 3.9% in June 2023 but then easing back to 3.5% 

The Quiz FREE
QuiznessDesk, Wednesday, May 25, 2022
The Quizmaster | Wed, 25 May 2022

This chilly weather is the perfect time for you to test your smarts in our daily quiz. Good luck!

Partner content
Small business lessons for attracting and retaining staff

Employers battling through the ‘Great Resignation’ are now faced with the ‘Great Brain Drain’.

Partner content
People leaders are key to wellbeing but still need help

One in three people say they have experienced an issue with an unsupportive manager